News
Featured
Vivonics is excited to announce we have received a $50,000 award from the Medical Technology Enterprise Consortium (MTEC) for commercialization of our IPASS (Intracranial Pressure Assessment and Screening System) system.
In conjunction with our collaborators at the University of North Texas Health Science Center at Fort Worth (UNTHSC), Vivonics has developed a novel type of diabetic footwear that monitors temperature and provides cooling therapy when needed in order to prevent diabetic ulcers.
Dr. Ryan Myers represented Vivonics at the Neurocritical Care Society 19th Annual Meeting, held October 26-29 in Chicago, Illinois.
Multiple Vivonics’ technologies and research were recognized at the 2021 Military Health System Research Symposium (MHSRS)
Vivonics and Liberating Technologies Inc. are thrilled to announce that we have been awarded a goverment grant to conduct a Clinical Trial for the co-developed Intrasocket Cooling Element (ICE) system.
“The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the UMASS Lowell and the UMass Medical School campuses of the University of Massachusetts.”
Come join Vivonics subsidiary, CranioSense, as Gordon Hirschman CEO & Founder presents at the 2020 M2D2 $200K Challenge.
“Cooling Insoles Reduce Foot Temperature, Tissue Breaking - The Insoles Could Prevent Amputations Caused by Diabetic Foot Ulcers” was published in the digital edition of Medical Design Briefs July 2020.
Today, June 23, marks the 8-year anniversary of the incorporation of Vivonics, Inc. by founder Gordon B. Hirschman.
On May 12th, 2020 Vivonics’ subsidiary, CranioSense, was highlighted as a Finalist for the 2020 M2D2 $200K Challenge. In a recent post on the M2D2 blog, CranioSense CEO Gordon Hirschman was interviewed about CranioSense’s development of IPASS, a device for noninvasive assessment of Intracranial Pressure (ICP) that would aid in the treatment of Traumatic Brain Injuries (TBI).
Vivonics’ is proud to announce, that our CEO Gordon Hirschman represented the Vivonics team at the 2020 virtual MedTech Innovator military pitching event on May 6th.
Vivonics is proud to announce that its subsidiary, CranioSense, has been selected as a finalist in the M2D2 $200k Challenge! Although the pitching event has been postponed due to the suspension of large-scale meetings due to the recent COVID-19 pandemic, we are honored to have been selected and look forward to participating when the event is rescheduled!
Dr. Ryan Myers attended the 5th MTEC Annual Meeting representing the Vivonics Team March 4th and March 5th in Houston, Texas. During the two-day event, Dr. Myers presented Vivonics’ areas of expertise, including our innovative, newly developed contactless monitoring system.
During the week of December 2nd, Dr. Michele Pierro, Ms. Saukhyda Deshmukh and Mr. Diego Alvarado participated in the 2019 Physiological Analysis Tool (PAT) Tech Sprint in Tampa, Florida.
"Temperature as a Causative Factor in Diabetic Foot Ulcers - A Call to Revisit Ulceration Pathomechanics" was published in September 2019 in the Journal of the American Podiatric Medical Association